DPP4 and type 2 diabetes mellitus: These include sulfonylureas (SU), pioglitazone, dipeptidyl peptidase-4 inhibitors (DPP4i) or sodium-glucose co-transporter-2 inhibitors (SGLT2i).1 3 NICE guidance recommends considering individual clinical circumstances when selecting T2DM drug treatment.